Показано 0 из 0
Дата |
---|
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.99
|
1.03
|
1.02
|
1.00
|
1.03
|
1.01
|
|
|
66 714.63
|
318.00
|
0.984
|
1.03
|
1.01
|
0.9734
|
1.03
|
0.9981
|
|
|
65 830.87
|
425.00
|
1.00
|
1.03
|
1.05
|
1.00
|
1.05
|
1.00
|
|
|
85 204.58
|
307.00
|
1.01
|
1.03
|
1.01
|
1.00
|
1.07
|
1.02
|
|
|
204 975.48
|
1 133.00
|
0.99
|
1.07
|
1.02
|
0.9785
|
1.07
|
1.04
|
|
|
75 594.56
|
320.00
|
0.982
|
1.00
|
0.9804
|
0.9804
|
1.05
|
1.02
|
|
|
48 086.53
|
220.00
|
0.9902
|
1.03
|
1.04
|
0.9734
|
1.04
|
0.9901
|
|
|
80 993.74
|
298.00
|
1.00
|
1.03
|
1.00
|
0.99
|
1.04
|
1.04
|
|
|
56 049.02
|
168.00
|
1.00
|
1.04
|
1.03
|
1.01
|
1.05
|
1.04
|
|
|
72 108.10
|
175.00
|
1.00
|
1.04
|
1.07
|
1.01
|
1.07
|
1.06
|
|
|
158 393.73
|
644.00
|
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.